EJNMMI Radiopharmacy and Chemistry (Oct 2022)
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
- Jun Toyohara,
- Mohammed Al-Qahtani,
- Ya-Yao Huang,
- Emiliano Cazzola,
- Sergio Todde,
- Shozo Furumoto,
- Renata Mikolajczak,
- Clemens Decristoforo,
- Nic Gillings,
- Min Yang,
- Raymond Reilly,
- Adriano Duatti,
- Antonia Denkova,
- Ralf Schirrmacher,
- Giuseppe Carlucci,
- Yann Seimbille,
- Zhaofei Liu,
- Beverley Ellis,
- Bart T. Cornelissen,
- Klaus Kopka,
- Emerson Bernardes
Affiliations
- Jun Toyohara
- PET Radiopharmaceutical Sciences, Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology
- Mohammed Al-Qahtani
- Cyclotron and Radiopharmaceuticals Department, King Faisal Specialist Hospital and Research Center (KFSHRC)
- Ya-Yao Huang
- Molecular Imaging Center, National Taiwan University
- Emiliano Cazzola
- Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Sacro Cuore-Don Calabria Hospital
- Sergio Todde
- University of Milano-Bicocca, Tecnomed Foundation
- Shozo Furumoto
- Cyclotron and Radioisotope Center (CYRIC), Tohoku University
- Renata Mikolajczak
- Radioisotope Centre POLATOM, National Centre for Nuclear Research (NCBJ)
- Clemens Decristoforo
- Department of Nuclear Medicine, Medical University of Innsbruck
- Nic Gillings
- Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital Rigshospitalet
- Min Yang
- NHC Key Laboratory of Nuclear Medicine, Jiangsu Institute of Nuclear Medicine
- Raymond Reilly
- Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto
- Adriano Duatti
- Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara
- Antonia Denkova
- Department of Radiation Science and Technology, Delft University of Technology
- Ralf Schirrmacher
- Department of Oncology, Cross Cancer Institute, University of Alberta
- Giuseppe Carlucci
- Department of Molecular and Medical Pharmacology, University of California, Los Angeles (UCLA)
- Yann Seimbille
- Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam
- Zhaofei Liu
- Medical Isotopes Research Center, Department of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Centre
- Beverley Ellis
- Manchester University NHS Foundation Trust
- Bart T. Cornelissen
- Department of Nuclear Medicine and Molecular Imaging, Groningen (UMCG), University Medical Center, University of Groningen
- Klaus Kopka
- Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Radiopharmaceutical Cancer Research
- Emerson Bernardes
- Energy and Nuclear Research Institute (IPEN-CNEN/SP), Cidade Universitária
- DOI
- https://doi.org/10.1186/s41181-022-00177-w
- Journal volume & issue
-
Vol. 7,
no. 1
pp. 1 – 18
Abstract
Abstract Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.
Keywords
- Highlight Articles
- Radiochemistry
- Radiopharmacy
- Radiopharmaceutical Sciences
- Nuclear Medicine
- Trends in Radiopharmaceutical Sciences
